Fluticasone propionate
| Overview | |
| Catalog # | bs-76342c-5mg |
| Product Name | Fluticasone propionate |
| Specifications | |
| Storage Buffer | Powder |
| Storage Condition | Stable for 2 years after receipt when stored at RT. |
| Target | |
| Product Information | CAS Number: 80474-14-2 Molecular formula: C25H31F3O5S Molecular weight: 500.57 Purity: >97% (NMR) Appearance: White powder. Solubility: Soluble in DMSO (20mg/ml) or DMF (20mg/ml). InChiKey: WMWTYOKRWGGJOA-CENSZEJFSA-N SMILES: O[C@H]1C[C@@]2(C)[C@](C[C@@H](C)[C@]2(OC(CC)=O)C(SCF)=O)([H])[C@]3([H])C[C@H](F)C4=CC(C=C[C@]4(C)[C@]31F)=O SMILES: [H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C |
| Description | Fluticasone propionate is a synthetic corticosteroid. It is a high affinity, selective glucocorticoid receptor agonist (Kd = 0.5nM). It is used as an anti-inflammatory agent for asthma. It has low systemic bioavailability and has been investigated for effectiveness as an inhaled or intranasal corticosteroid to reduce airflow obstruction related to asthma, allergic rhinitis and other airway diseases. It potently stimulates glucocorticoid receptor-mediated transactivation of gene expression and enhances human eosinophil apoptosis in vitro. It also potentiates KV1 channels (EC50 = 37nM). |